Allison Frisbee
Direttore operativo presso KRONOS BIO, INC.
Patrimonio netto: 200 420 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Allison Frisbee
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Allison Frisbee tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Director/Board Member | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Cambridge | College/University | Graduate Degree | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Chief Investment Officer | ||
| The University of Southampton | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman | |
Bellco Capital LLC
 Bellco Capital LLC Investment ManagersFinance Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA. | Investment Managers | Founder Chief Executive Officer | |
| KITE PHARMA INC | Biotechnology | Founder Founder Chief Executive Officer | |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Founder Consultant / Advisor | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Founder Consultant / Advisor | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman Director/Board Member | |
| Breakthrough Services LLC | Director/Board Member Chairman | ||
Breakthrough Properties Growth Portfolio I LP
 Breakthrough Properties Growth Portfolio I LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, Breakthrough Properties Growth Portfolio I LP functions as a pooled investment and private equity fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Corporate Officer/Principal Director of Finance/CFO | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Director/Board Member | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Regno Unito | 3 |
| Germania | 2 |
Settori
| Health Technology | 24 |
| Finance | 13 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 171 |
| Corporate Officer/Principal | 79 |
| Independent Dir/Board Member | 45 |
| Founder | 36 |
| Director of Finance/CFO | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Otello Stampacchia | 37 |
| David Tanen | 25 |
| John Martin | 20 |
| Sandra Gardiner | 19 |
| Jakob Loven | 19 |
| Barbara Kosacz | 17 |
| Marianne de Backer | 14 |
| Roshawn Blunt | 14 |
| Tai Yin Yang | 12 |
| Phillip Gutry | 12 |
| Norbert W. Bischofberger | 11 |
| Rebecka Belldegrun | 10 |
| Elena Ridloff | 10 |
- Borsa valori
- Insiders
- Allison Frisbee
- Connessioni Società
